Invitrogen™ ELISA Kit CD86 / Human B7-2

Ref.: BL-RE-106187Manufacturer ref.: EH99RBX10 10 x 96 tests
Price on request
Custom pricing depending on configuration and quantity.

The CD86 protein is one of two ligands (the other CD80) for CTLA4 and CD28. The CD86 protein acts as a costimulation molecule by obtaining the help of T cells during the presentation of antigen. The presentation of antigen in the absence...

Accession number
P42081
Dose range
0.82 to 200 ng/ml
Sensitivity of the dosage
0.82 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

The CD86 protein is one of two ligands (the other CD80) for CTLA4 and CD28. The CD86 protein acts as a costimulation molecule by obtaining the help of T cells during the presentation of antigen. The presentation of antigen in the absence...

The CD86 protein is one of two ligands (the other CD80) for CTLA4 and CD28. The CD86 protein acts as a costimulation molecule by obtaining the help of T cells during the presentation of antigen. The presentation of antigen in the absence of sufficient costing involving a CD86/CD80 protein may lead to tolerance. CD80 protein appears to play a distinct role from CD80 protein in the differentiation of auxiliary T cells. CD86 protein is a Type I membrane protein that is part of the immunoglobulin superfamily. CD86 protein is expressed by antigen cells and is the ligand of two proteins at the cell surface of T cells, CD28 antigen and the protein associated with cytotoxic T lymphocyte 4. The binding of CD86 to CD28 antigen is a costimulation signal for T cell activation. The binding of the CD86 protein to the protein associated with cytotoxic T-lymphocyte 4 negatively regulates T-cell activation and decreases the immune response. The alternative splicing results in two transcription variants that encode different isoforms of CD86. Other transcription variants were described for CD86, but their total length sequences were not determined. Diseases associated with CD86 protein dysfunction include epidermoid carcinoma of the gallbladder and myocarditis.

Sensitivity

Sensitivity of dosage: 0.82 ng/ml.

Measurement range

Dosing range: 0.82 to 200 ng/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Coefficient of intradose variation < 10%, interdose < 12%.

Target

Target: CD86.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17777863
Specifications
Accession numberP42081
Dose range0.82 to 200 ng/ml
Sensitivity of the dosage0.82 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)942
Gene symbol(s)CD86
Coefficient of inter-dose variation< 12%
Coefficient of intra-dose variation< 10%
Contents of kits96-well pre-coated sheetings, etc., at the same time as the pre-casting plate, at the same time as the pre-casting plate.
Marker or dyeHRP
Quantity10 x 96 tests
Regulatory statusRUO
TargetCD86
Test time1 h 20 min
Physical characteristics
Volume of sampleSerum, 50 μl-Plasma, 50 μl-Surnatant, 50 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH99RBX10
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.